Is Omada Health, Inc. Common Stock (OMDA) overvalued? · rev $68.0M
Omada Health, Inc. Common Stock (OMDA) is a health information services company listed on NASDAQ.
This page asks whether Omada Health, Inc. Common Stock (OMDA) looks expensive on cached numbers — not a short thesis.
Latest reported OMDA revenue for 2025-09-30 was $68.0M. Net income was -$3.2M. Revenue was up 10.9% from 2025-06-30 to 2025-09-30. OMDA currently screens at market cap $1.03B.
OMDA currently screens at market cap $1.03B. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next OMDA 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the OMDA stock page for the full model, not this heading.
Not investment advice.